The FDA–AACR Oncology Educational Fellowship is a one-year professional development program that trains early-career cancer researchers and clinicians in oncology drug development, regulatory science, and FDA review processes, with the goal of building a workforce skilled in translating cancer science into approved therapies.

- Terminal advanced degree (MD, DO, PhD, MD/PhD, PharmD, MBBS, or equivalent) completed within the past 10 years. - Current AACR membership or submitted membership application before applying. - Strong written English skills. - Ability to fully participate in monthly virtual sessions and both in-person events (AACR Annual Meeting 2027 and Project ODAC Odyssey at FDA). - Quality of professional biography (up to 250 words) and statement of interest (up to 300 words) – likely assessed for clarity, motivation, and alignment with oncology drug development/regulatory science. - Two recommendation letters (max 2 pages each) from individuals who can assess scientific or clinical experience. - No salary/stipend provided; travel/lodging for in-person events covered by AACR. - Approximately 20 fellows selected per cohort.

The page does not list named past winners, but typical cohorts consist of early-career oncologists, cancer researchers, and clinician-scientists (MD, PhD, PharmD, MBBS) from academia, industry, or clinical settings who are interested in regulatory science and drug development. They often have some oncology research or clinical experience and seek to understand FDA processes.

The ideal applicant is an early-career cancer researcher or clinician with a strong oncology-focused background, a clear interest in regulatory science and drug development, and a desire to learn how FDA reviews new cancer therapies. They are an AACR member, have completed a terminal degree within 10 years, and can articulate how the fellowship will advance their career in oncology.